Prime Medicine (PRME) Stock Chart & Stock Price History $2.64 -0.27 (-9.28%) (As of 04:00 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends Prime Medicine Stock Price Performance 5 Day Performance-0.35%1 Month Performance-9.75%3 Month Performance-27.89%6 Month Performance-54.30%Year-To-Date Performance-67.61%1 Year Performance-67.79% Receive PRME Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Prime Medicine and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin PRME Stock Chart for Wednesday, December, 18, 2024 PRME Chart by TradingView Prime Medicine Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/17/2024$3.00$2.91-3.00%$3.01$2.891.07 million shs$381.68 million12/16/2024$2.88$3.00+4.17%$3.04$2.831.39 million shs$393.48 million12/13/2024$3.01$2.88-4.32%$3.01$2.811.17 million shs$377.74 million12/12/2024$3.16$3.01-4.75%$3.13$2.941.38 million shs$394.80 million12/11/2024$3.22$3.16-1.86%$3.29$3.07703,970 shs$414.47 million12/10/2024$3.22$3.22$3.40$3.181.63 million shs$422.34 million Get the Latest News and Ratings for PRME and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Prime Medicine and its competitors with MarketBeat's FREE daily newsletter. 12/09/2024$3.27$3.22-1.53%$3.50$3.182.00 million shs$422.34 million12/06/2024$2.97$3.27+10.10%$3.28$2.98815,319 shs$428.89 million12/05/2024$3.19$2.97-6.90%$3.18$2.951.01 million shs$389.55 million12/04/2024$3.13$3.19+1.92%$3.25$3.12803,928 shs$418.40 million12/03/2024$3.45$3.13-9.28%$3.48$3.11963,045 shs$410.53 million12/02/2024$3.29$3.45+4.86%$3.52$3.30981,662 shs$452.50 million11/29/2024$3.30$3.29-0.30%$3.41$3.271.48 million shs$432.83 million11/28/2024$3.30$3.30$3.39$3.28756,500 shs$432.83 million11/27/2024$3.34$3.30-1.20%$3.39$3.28756,340 shs$432.83 million11/26/2024$3.33$3.34+0.30%$3.41$3.22949,363 shs$438.08 million11/25/2024$3.20$3.33+4.06%$3.53$3.251.67 million shs$436.77 million11/22/2024$2.99$3.20+7.02%$3.29$2.951.53 million shs$419.71 million11/21/2024$2.99$2.99$3.07$2.85844,967 shs$392.17 million11/20/2024$3.17$2.99-5.68%$3.19$2.901.15 million shs$392.17 million11/19/2024$3.18$3.17-0.31%$3.24$3.06986,867 shs$415.78 million11/18/2024$3.35$3.18-4.93%$3.39$3.152.07 million shs$417.09 million Related Companies BioCryst Pharmaceuticals Stock Price Chart Novavax Stock Price Chart Immunocore Stock Price Chart Mesoblast Stock Price Chart bluebird bio Stock Price Chart Vir Biotechnology Stock Price Chart Adaptive Biotechnologies Stock Price Chart Poseida Therapeutics Stock Price Chart Immatics Stock Price Chart LENZ Therapeutics Stock Price Chart Receive PRME Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Prime Medicine and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:PRME) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prime Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Prime Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRME Stock Alerts